UBS Group AG Registered Ordinary Shares (UBS)

Centene withdrew its 2025 earnings guidance on Tuesday due to an expected fall in revenue under plans associated with Obamacare.

Shares of health coverage company Centene (NYSE:CNC) fell 39.4% in the afternoon session after the company unexpectedly withdrew its full-year 2025 financial guidance, citing significantly higher-than-anticipated costs in its insurance marketplace and Medicaid businesses. 

The need to improve the speed and efficiency of warehouses is driving more automation. And that bodes well for Symbotic stock and others.

Guggenheim cut McDonald’s price target by $5 to $305 as the burger chain battles tepid demand in the United States, with macro environmental pressure weighing on consumer buying patterns.

Tesla is leaning on overseas upgrades as domestic headwinds mount, including a sharp stock decline, potential loss of EV tax credits, and bearish delivery forecasts from top brokerages.

JPMorgan sees deliveries falling from 444,000 a year ago to "just" 360,000 vehicles, representing a "sizable" 8% shortfall versus the Bloomberg consensus forecast for 392,000 deliveries, as per TheFly.

UBS reiterated its 'Buy' rating on McDonald's and predicts a 21% upside to the stock price.

Netflix and Spotify stock are in record-high territory, and Wall Street analysts are raising their price targets to keep up.

Tesla’s rally is stalling, and while bulls still see upside, fresh bearish calls mean the next few weeks could make or break the stock’s fortunes.

Investment bank JPMorgan on Thursday cut its price target on Apple stock, citing growing challenges for the iPhone maker.

Afshar was promoted last year to oversee sales and manufacturing operations in North America and Europe. He previously worked in the office of the CEO.

Meta stock gained Thursday, adding to a recent rally. UBS hiked its price target on the social media giant.

Under the terms of the agreement, Kymera is eligible to receive up to $750 million in total payments, including up to $85 million in upfront and potential option exercise payments.

UBS has a ‘Sell’ rating and $215 price target on Tesla shares, which represents a 37% downside to the stock’s closing price on Tuesday.

Broader markets outperformed, led by gains in IT, media, consumer durables, and auto stocks, while select stocks like MCX and IndiaMART rallied on positive brokerage commentary.

The analyst forecasts continued bullish momentum, as the stock has broken out above key resistance levels, triggering buying interest.

Broader markets rallied for the second consecutive session as sentiment turned bullish and volatility cooled.

The research firm flagged technical and regulatory hurdles that could slow Tesla’s robotaxi rollout, warning the autonomy opportunity is already priced in.

For many emerging economies, gold serves as a form of geopolitical insurance.

While Tesla appears to be well-positioned, the autonomous ride-hailing opportunity is already priced into the stock, UBS analyst Joseph Spak told investors in a research note.

The company reaffirmed its full-year adjusted core profit guidance and noted that oncology cost trends remained below forecast through the first two-thirds of the quarter.

The global market for humanoid robots is set to soar, with a UBS report predicting a significant increase in their numbers by 2050. This forecast is expected to have a substantial impact on various industries.